Pharma Summit: Sanofi president Elias Zerhouni calls for harmony and evolution in pharma

14 March 2014
elias-big

Health care is a human right and the pharma industry must evolve to meet future challenges, claimed keynote speaker Elias Zerhouni, president of Global R&D at French drug major Sanofi (Euronext: SAN), at The Economist Pharma Summit in London yesterday.

In a passionate speech on the future of pharma, Mr Zerhouni (pictured) outlined a number of challenges facing the industry, in particular, the needs of patients who are demanding improved health care from providers, who in turn are facing higher health care costs to pay for this medical innovation.

He said that patient needs are heterogeneous and patients are suffering from “a huge disease burden that is not being addressed by governments.”

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical